[Effect of phenformin and stanozol administration on lipid metabolism in patients with occlusive vascular diseases].
D000328:Adult; D000368:Aged; D001162:Arteriosclerosis Obliterans / Q000188:drug therapy* / Q000378:metabolism; D005260:Female; D006801:Humans; D007866:Leg / Q000098:blood supply*; D050356:Lipid Metabolism; D008297:Male; D008875:Middle Aged; D010629:Phenformin / Q000494:pharmacology* / Q000627:therapeutic use; D013197:Stanozolol / Q000494:pharmacology* / Q000627:therapeutic use; D013919:Thromboangiitis Obliterans / Q000188:drug therapy* / Q000378:metabolism
D013197:Stanozolol; D010629:Phenformin
Wpływ stosowanie fenforminy is stanozolu na gospodarke tłuszczowa u chorych z zarostowymi zmanimi naczyń kończyn dolnych.